Andrew Schmidt
Impact in
-
- Cancer Immunotherapy and Biomarkers
- COVID-19 and healthcare impacts
-
- Cancer Genomics and Diagnostics
Papers in
-
- Renal cell carcinoma treatment 14
- Oncology 13
- COVID-19 and healthcare impacts 6
- Cancer Immunotherapy and Biomarkers 5
- Co-authors
- Toni K. Choueiri (16 shared papers)Rana R. McKay (11 shared papers)Bradley A. McGregor (7 shared papers)Ziad Bakouny (10 shared papers)Arlene O. Siefker‐Radtke (2 shared papers)Wanling Xie (4 shared papers)Praful Ravi (2 shared papers)Atish D. Choudhury (1 shared paper)
- Journals
- Journal of Clinical Oncology (11 papers)Annals of Oncology (2 papers)American Society of Clinical Oncology Educational Book (2 papers)Blood (1 paper)Cancer (1 paper)
- Partner nations
- United StatesAustraliaCanada
In The Last Decade
Andrew Schmidt
27 papers receiving 264 citations
Peers
Comparison fields: 5 of 61
- Oncology 126
- Cancer Research 56
- Pulmonary and Respiratory Medicine 109
- Surgery 77
- Genetics 16
Countries citing papers authored by Andrew Schmidt
This map shows the geographic impact of Andrew Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Schmidt more than expected).
Fields of papers citing papers by Andrew Schmidt
This network shows the impact of papers produced by Andrew Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Schmidt. The network helps show where Andrew Schmidt may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Schmidt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 66 | |
| 2 | 2020 | 33 | |
| 3 | 2010 | 16 | |
| 4 | 2021 | 15 | |
| 5 | 2020 | 13 | |
| 6 | 2022 | 12 | |
| 7 | 2021 | 12 | |
| 8 | 2006 | 12 | |
| 9 | 2020 | 11 | |
| 10 | 2020 | 11 | |
| 11 | 2021 | 9 | |
| 12 | 2020 | 7 | |
| 13 | 2021 | 7 | |
| 14 | 2021 | 6 | |
| 15 | 2020 | 6 | |
| 16 | 2021 | 5 | |
| 17 | 2020 | 4 | |
| 18 | 2022 | 4 | |
| 19 | 2022 | 3 | |
| 20 | 2022 | 3 |
About Andrew Schmidt
Andrew Schmidt is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Economics and Econometrics and Molecular Biology, having authored 30 papers that have together received 267 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (14 papers), Economic and Financial Impacts of Cancer (9 papers), Cancer Genomics and Diagnostics (8 papers), COVID-19 and healthcare impacts (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Renal and related cancers (4 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Breast Cancer Treatment Studies (2 papers). The work is most often cited by research in Oncology (126 citations), Cancer Research (56 citations), Pulmonary and Respiratory Medicine (109 citations), Surgery (77 citations) and Genetics (16 citations). Andrew Schmidt has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Toni K. Choueiri, Rana R. McKay, Bradley A. McGregor, Ziad Bakouny, Arlene O. Siefker‐Radtke, Wanling Xie, Praful Ravi, Atish D. Choudhury, Mehmet Asım Bilen and Amir Mortazavi. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, American Society of Clinical Oncology Educational Book, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.